• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. BONE WAX 2.5GR::; WAX, BONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. BONE WAX 2.5GR::; WAX, BONE Back to Search Results
Catalog Number XCW810T
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erythema (1840); Inflammation (1932)
Event Date 03/16/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).A manufacturing record evaluation was performed for the finished device product code w810t lot ma7bqlm, and no non-conformances were identified.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.  to date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, gender, weight, bmi at the time of index procedure date and name of the index surgical procedure? the diagnosis and indication for the index surgical procedure? in what location was the bone wax used? what were the current symptoms following the index surgical procedure? onset date? other relevant patient history/concomitant medications if applicable, will the product be returned, return date, tracking information? what is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient¿s current status?.
 
Event Description
It was reported that the patient underwent surgery for fracture of left leg on an unknown date and suture was used.Three days following the procedure, the patient experienced erythema and inflammation on the left leg.Local drainage and anti-inflammatory ceftriaxone sodium were given.Five days' usage of medication let the inflammation disappear.The patient recovered to normal after a week's rehabilitation treatment.Additional information has been requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BONE WAX 2.5GR::
Type of Device
WAX, BONE
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
Manufacturer (Section G)
ETHICON INC.-UK
simpson parkway
kirkton campus
livingston
Manufacturer Contact
elba bello
p.o. box 151, route 22 west
somerville, NJ 08876
9082183429
MDR Report Key9997048
MDR Text Key188894317
Report Number2210968-2020-03476
Device Sequence Number1
Product Code MTJ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
PRE-AMEND
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 04/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/24/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2023
Device Catalogue NumberXCW810T
Device Lot NumberMA7BQLM
Was Device Available for Evaluation? No
Date Manufacturer Received04/09/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/15/2018
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age32 YR
-
-